{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:28:22Z","timestamp":1784021302027,"version":"3.55.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501672"],"award-info":[{"award-number":["81501672"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602774"],"award-info":[{"award-number":["81602774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013059","name":"Jiangsu Provincial Medical Youth Talent","doi-asserted-by":"publisher","award":["QNRC2016096"],"award-info":[{"award-number":["QNRC2016096"]}],"id":[{"id":"10.13039\/501100013059","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.lfs.2019.117174","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T11:28:12Z","timestamp":1576236492000},"page":"117174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Emerging evidence for the roles of peptide in hypertrophic scar"],"prefix":"10.1016","volume":"241","author":[{"given":"Jiajun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3390\/ijms19030711","article-title":"Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2019.117174_bb0010","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.ASW.0000527576.27489.0f","article-title":"Insights into the pathophysiology of hypertrophic scars and keloids: how do they differ?","volume":"31","author":"Ghazawi","year":"2018","journal-title":"Adv. Skin Wound Care"},{"issue":"6","key":"10.1016\/j.lfs.2019.117174_bb0015","first-page":"451","article-title":"Techniques for optimizing surgical scars, part 2: hypertrophic scars and keloids","volume":"15","author":"Potter","year":"2017","journal-title":"Skinmed"},{"issue":"20","key":"10.1016\/j.lfs.2019.117174_bb0020","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/cmdc.201600288","article-title":"Oral administration of peptide-based drugs: beyond Lipinski's rule","volume":"11","author":"Santos","year":"2016","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.lfs.2019.117174_bb0025","doi-asserted-by":"crossref","first-page":"e0181748","DOI":"10.1371\/journal.pone.0181748","article-title":"THPdb: database of FDA-approved peptide and protein therapeutics","volume":"12","author":"Usmani","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2019.117174_bb0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.lfs.2019.117174_bb0035","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nri2431","article-title":"Do T cells need endogenous peptides for activation?","volume":"8","author":"Gascoigne","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2019.117174_bb0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12079-013-0195-5","article-title":"The molecular mechanism of hypertrophic scar","volume":"7","author":"Zhu","year":"2013","journal-title":"J. Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.lfs.2019.117174_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1566523044578004","article-title":"TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy","volume":"4","author":"Liu","year":"2004","journal-title":"Curr. Gene Ther."},{"issue":"43","key":"10.1016\/j.lfs.2019.117174_bb0050","doi-asserted-by":"crossref","first-page":"27155","DOI":"10.1074\/jbc.272.43.27155","article-title":"Transforming growth factor beta peptide antagonists and their conversion to partial agonists","volume":"272","author":"Huang","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2019.117174_bb0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/BCR.0b013e31819a6369","article-title":"A novel TGF-beta antagonist speeds reepithelialization and reduces scarring of partial thickness porcine burns","volume":"30","author":"Singer","year":"2009","journal-title":"J. Burn Care Res."},{"issue":"7","key":"10.1016\/j.lfs.2019.117174_bb0060","first-page":"1189","article-title":"Inhibitory effect of TGF-beta peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts","volume":"54","author":"Wang","year":"2016","journal-title":"Pharm. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2019.117174_bb0065","doi-asserted-by":"crossref","first-page":"e0144489","DOI":"10.1371\/journal.pone.0144489","article-title":"Effect of P144(R) (anti-TGF-beta) in an \u201cin vivo\u201d human hypertrophic scar model in nude mice","volume":"10","author":"Qiu","year":"2015","journal-title":"PLoS One"},{"issue":"Pt 3","key":"10.1016\/j.lfs.2019.117174_bb0070","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1242\/jcs.108.3.985","article-title":"Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring","volume":"108","author":"Shah","year":"1995","journal-title":"J. Cell Sci."},{"issue":"11","key":"10.1016\/j.lfs.2019.117174_bb0075","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1002\/jps.23725","article-title":"Evaluation of a highly skin permeable low-molecular-weight protamine conjugated epidermal growth factor for novel burn wound healing therapy","volume":"102","author":"Lee","year":"2013","journal-title":"J. Pharm. Sci."},{"issue":"136","key":"10.1016\/j.lfs.2019.117174_bb0080","doi-asserted-by":"crossref","first-page":"136ra171","DOI":"10.1126\/scitranslmed.3003421","article-title":"A peptide derived from endostatin ameliorates organ fibrosis","volume":"4","author":"Yamaguchi","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.lfs.2019.117174_bb0085","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/iwj.12895","article-title":"Growth hormone-releasing peptide 6 prevents cutaneous hypertrophic scarring: early mechanistic data from a proteome study","volume":"15","author":"Fernandez-Mayola","year":"2018","journal-title":"Int. Wound J."},{"key":"10.1016\/j.lfs.2019.117174_bb0090","doi-asserted-by":"crossref","DOI":"10.1177\/1179546817694558","article-title":"Synthetic growth hormone-releasing peptides (GHRPs): a historical appraisal of the evidences supporting their cytoprotective effects","volume":"11","author":"Berlanga-Acosta","year":"2017","journal-title":"Clin. Med. Insights Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117174_bb0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.sxmr.2017.02.004","article-title":"The safety and efficacy of growth hormone secretagogues","volume":"6","author":"Sigalos","year":"2018","journal-title":"Sex. Med. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2019.117174_bb0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/papr.12272","article-title":"Prostaglandin E1 treatment for lumbar spinal canal stenosis: review of the literature","volume":"16","author":"Yoshihara","year":"2016","journal-title":"Pain Pract."},{"issue":"1","key":"10.1016\/j.lfs.2019.117174_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00246-015-1251-0","article-title":"Long-term prostaglandin E1 infusion for newborns with critical congenital heart disease","volume":"37","author":"Aykanat","year":"2016","journal-title":"Pediatr. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0923-1811(96)00577-4","article-title":"Effects of prostaglandin E1 on cultured dermal fibroblasts from normal and hypertrophic scarred skin","volume":"14","author":"Zhou","year":"1997","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2019.117174_bb0115","doi-asserted-by":"crossref","first-page":"e0179614","DOI":"10.1371\/journal.pone.0179614","article-title":"Lipo-PGE1 suppresses collagen production in human dermal fibroblasts via the ERK\/Ets-1 signaling pathway","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.lfs.2019.117174_bb0120","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1111\/bph.14489","article-title":"Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-beta-activated kinase 1 (TAK1) pathways in mice","volume":"175","author":"Tan","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0125","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/01.PRS.0000047403.23105.66","article-title":"Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7)","volume":"111","author":"Rodgers","year":"2003","journal-title":"Plast. Reconstr. Surg."},{"issue":"4","key":"10.1016\/j.lfs.2019.117174_bb0130","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1167\/iovs.15-18515","article-title":"NorLeu3A(1-7) accelerates clear corneal full thickness wound healing","volume":"57","author":"Abdallah","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1067-1927.2005.130314.x","article-title":"Effect of NorLeu3-A(1-7) on scar formation over time after full-thickness incision injury in the rat","volume":"13","author":"Rodgers","year":"2005","journal-title":"Wound Repair Regen."},{"issue":"11","key":"10.1016\/j.lfs.2019.117174_bb0140","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1517\/13543784.2011.619976","article-title":"Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7)","volume":"20","author":"Rodgers","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.lfs.2019.117174_bb0145","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/01.RES.0000117070.86556.9F","article-title":"B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation","volume":"94","author":"Kapoun","year":"2004","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.lfs.2019.117174_bb0150","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1553-2712.2008.00243.x","article-title":"The effects of brain natriuretic peptide on scar formation in incisional rat wounds","volume":"15","author":"Taira","year":"2008","journal-title":"Acad. Emerg. Med."},{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1524-475X.2010.00589.x","article-title":"Double-edged effects of neuropeptide substance P on repair of cutaneous trauma","volume":"18","author":"Jing","year":"2010","journal-title":"Wound Repair Regen."},{"issue":"1","key":"10.1016\/j.lfs.2019.117174_bb0160","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/molecules21010072","article-title":"The structure-activity relationship of the antioxidant peptides from natural proteins","volume":"21","author":"Zou","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2019.117174_bb0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biochi.2014.06.023","article-title":"Identification of peptide products from enzymatic degradation of amyloid beta","volume":"105","author":"Rogeberg","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.lfs.2019.117174_bb0170","doi-asserted-by":"crossref","first-page":"648108","DOI":"10.1155\/2015\/648108","article-title":"GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration","volume":"2015","author":"Pickart","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.lfs.2019.117174_bb0175","first-page":"954","article-title":"Effect of GLY-HIS-LYS and its copper complex on TGF-beta secretion in normal human dermal fibroblasts","volume":"71","author":"Gruchlik","year":"2014","journal-title":"Acta Pol. Pharm."},{"issue":"2","key":"10.1016\/j.lfs.2019.117174_bb0180","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/wrr.12520","article-title":"GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis","volume":"25","author":"Wang","year":"2017","journal-title":"Wound Repair Regen."},{"issue":"1","key":"10.1016\/j.lfs.2019.117174_bb0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/14712598.2012.634793","article-title":"Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications","volume":"12","author":"Goldstein","year":"2012","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0190","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/wrr.12430","article-title":"Blood vessel occlusion in peri-burn tissue is secondary to erythrocyte aggregation and mitigated by a fibronectin-derived peptide that limits burn injury progression","volume":"24","author":"Asif","year":"2016","journal-title":"Wound Repair Regen."},{"issue":"4","key":"10.1016\/j.lfs.2019.117174_bb0195","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/jid.2013.420","article-title":"Fibronectin peptides that bind PDGF-BB enhance survival of cells and tissue under stress","volume":"134","author":"Lin","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.lfs.2019.117174_bb0200","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/exd.13518","article-title":"Blood vessel occlusion with erythrocyte aggregates causes burn injury progression-microvasculature dilation as a possible therapy","volume":"27","author":"Clark","year":"2018","journal-title":"Exp. Dermatol."},{"issue":"11","key":"10.1016\/j.lfs.2019.117174_bb0205","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.jid.2018.04.023","article-title":"Elastase digestion of fibronectin releases an epiviosamine peptide with fibroblast growth and survival activity","volume":"138","author":"Lin","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2019.117174_bb0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2018.08.009","article-title":"Current and upcoming therapies to modulate skin scarring and fibrosis","volume":"146","author":"Coentro","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.lfs.2019.117174_bb0215","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cub.2014.05.006","article-title":"Resolution mediator chemerin15 reprograms the wound microenvironment to promote repair and reduce scarring","volume":"24","author":"Cash","year":"2014","journal-title":"Curr. Biol."},{"issue":"4","key":"10.1016\/j.lfs.2019.117174_bb0220","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.20071601","article-title":"Synthetic chemerin-derived peptides suppress inflammation through ChemR23","volume":"205","author":"Cash","year":"2008","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.lfs.2019.117174_bb0225","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1080\/10408398.2016.1264064","article-title":"Bioactive whey peptide particles: an emerging class of nutraceutical carriers","volume":"58","author":"Madadlou","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"11","key":"10.1016\/j.lfs.2019.117174_bb0230","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1017\/S0007114510002692","article-title":"Whey peptides improve wound healing following caesarean section in rats","volume":"104","author":"Wang","year":"2010","journal-title":"Br. J. Nutr."},{"issue":"8","key":"10.1016\/j.lfs.2019.117174_bb0235","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1002\/jcp.26407","article-title":"Comparative peptidomic profile between human hypertrophic scar tissue and matched normal skin for identification of endogenous peptides involved in scar pathology","volume":"233","author":"Li","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2019.117174_bb0240","doi-asserted-by":"crossref","first-page":"116674","DOI":"10.1016\/j.lfs.2019.116674","article-title":"Endogenous peptide LYENRL prevents the activation of hypertrophic scar-derived fibroblasts by inhibiting the TGF-beta1\/Smad pathway","volume":"231","author":"Ji","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2019.117174_bb0245","article-title":"TGFbeta1 mimetic peptide modulates immune response to grass pollen allergens in mice","author":"Araujo","year":"2019","journal-title":"Allergy"},{"issue":"28","key":"10.1016\/j.lfs.2019.117174_bb0250","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1039\/C7OB01092C","article-title":"Self-assembly of bioactive peptides, peptide conjugates, and peptide mimetic materials","volume":"15","author":"Edwards-Gayle","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.lfs.2019.117174_bb0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biomaterials.2017.04.040","article-title":"Heparin mimetic peptide nanofiber gel promotes regeneration of full thickness burn injury","volume":"134","author":"Yergoz","year":"2017","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.lfs.2019.117174_bb0260","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1039\/C7BM00251C","article-title":"Diabetic wound regeneration using heparin-mimetic peptide amphiphile gel in db\/db mice","volume":"5","author":"Senturk","year":"2017","journal-title":"Biomater. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2019.117174_bb0265","doi-asserted-by":"crossref","first-page":"e22139","DOI":"10.1371\/journal.pone.0022139","article-title":"Collagen-binding peptidoglycans inhibit MMP mediated collagen degradation and reduce dermal scarring","volume":"6","author":"Stuart","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0270","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/BCR.0000000000000459","article-title":"Blockade of IgM-mediated inflammation alters wound progression in a swine model of partial-thickness burn","volume":"38","author":"Sadeghipour","year":"2017","journal-title":"J. Burn Care Res."},{"issue":"5","key":"10.1016\/j.lfs.2019.117174_bb0275","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/PRS.0b013e3182865c3f","article-title":"Through gap junction communications, co-cultured mast cells and fibroblasts generate fibroblast activities allied with hypertrophic scarring","volume":"131","author":"Foley","year":"2013","journal-title":"Plast. Reconstr. Surg."},{"issue":"2","key":"10.1016\/j.lfs.2019.117174_bb0280","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/17460751.4.2.205","article-title":"Connexin43 carboxyl-terminal peptides reduce scar progenitor and promote regenerative healing following skin wounding","volume":"4","author":"Ghatnekar","year":"2009","journal-title":"Regen. Med."},{"issue":"6","key":"10.1016\/j.lfs.2019.117174_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061778","article-title":"Connexin 43-based therapeutics for dermal wound healing","volume":"19","author":"Montgomery","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0290","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jid.2016.11.006","article-title":"Controlled trial evaluating a Cx43-mimetic peptide in cutaneous scarring","volume":"137","author":"Grek","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.lfs.2019.117174_bb0295","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCRESAHA.110.235747","article-title":"A peptide mimetic of the connexin43 carboxyl terminus reduces gap junction remodeling and induced arrhythmia following ventricular injury","volume":"108","author":"O\u2019Quinn","year":"2011","journal-title":"Circ. Res."},{"issue":"16","key":"10.1016\/j.lfs.2019.117174_bb0300","doi-asserted-by":"crossref","first-page":"e012385","DOI":"10.1161\/JAHA.119.012385","article-title":"Interaction of alpha carboxyl terminus 1 peptide with the connexin 43 carboxyl terminus preserves left ventricular function after ischemia-reperfusion injury","volume":"8","author":"Jiang","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.lfs.2019.117174_bb0305","first-page":"L843","article-title":"Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo","volume":"294","author":"Tourkina","year":"2008","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"2","key":"10.1016\/j.lfs.2019.117174_bb0310","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jdermsci.2010.10.018","article-title":"Caveolin 1 inhibits transforming growth factor-beta1 activity via inhibition of Smad signaling by hypertrophic scar derived fibroblasts in vitro","volume":"62","author":"Zhang","year":"2011","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0315","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/jid.2008.264","article-title":"Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts","volume":"129","author":"Lopes","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.lfs.2019.117174_bb0320","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1002\/jps.22087","article-title":"Internalization and intracellular trafficking of a PTD-conjugated anti-fibrotic peptide, AZX100, in human dermal keloid fibroblasts","volume":"99","author":"Flynn","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"17","key":"10.1016\/j.lfs.2019.117174_bb0325","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.biomaterials.2014.02.047","article-title":"Ultrashort peptide nanofibrous hydrogels for the acceleration of healing of burn wounds","volume":"35","author":"Loo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.lfs.2019.117174_bb0330","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0335","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0340","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0345","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0350","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0355","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0360","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0365","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0370","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0375","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0380","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0385","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0390","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0395","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0400","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0405","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0410","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0415","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0420","author":"US National Library of Medicine"},{"key":"10.1016\/j.lfs.2019.117174_bb0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.taap.2018.09.026","article-title":"Effect of N-(2-aminoethyl) ethanolamine on hypertrophic scarring changes in vitro: finding novel anti-fibrotic therapies","volume":"362","author":"Chen","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117174_bb0430","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00006534-199601000-00019","article-title":"Topical putrescine (Fibrostat) in treatment of hypertrophic scars: phase II study","volume":"97","author":"Dolynchuk","year":"1996","journal-title":"Plast. Reconstr. Surg."},{"issue":"7","key":"10.1016\/j.lfs.2019.117174_bb0435","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jid.2017.02.978","article-title":"Pleiotropic FTY720 is a specific and potent therapy for hypertrophic scars","volume":"137","author":"Shi","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117174_bb0440","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/PRS.0000000000001889","article-title":"Topical application of a silicone gel sheet with verapamil microparticles in a rabbit model of hypertrophic scar","volume":"137","author":"Rha","year":"2016","journal-title":"Plast. Reconstr. Surg."},{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0445","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/SLA.0000000000002926","article-title":"Reduced postburn hypertrophic scarring and improved physical recovery with yearlong administration of oxandrolone and propranolol","volume":"268","author":"Herndon","year":"2018","journal-title":"Ann. Surg."},{"issue":"24","key":"10.1016\/j.lfs.2019.117174_bb0450","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1016\/j.bmcl.2008.10.036","article-title":"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents","volume":"18","author":"Bailey","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.lfs.2019.117174_bb0455","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.111.187328","article-title":"LCB 03-0110, a novel pan-discoidin domain receptor\/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation","volume":"340","author":"Sun","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519311026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519311026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:30:33Z","timestamp":1758400233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519311026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":91,"alternative-id":["S0024320519311026"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117174","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging evidence for the roles of peptide in hypertrophic scar","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117174"}}